dejerine
04-14-2005, 11:37 AM
A recent article on Medscape on Neuropathic Pain left me puzzled. It was written by an anesthesiologist.
See
http://www.neurology.org/cgi/content/abstract/62/5_suppl_2/S30
It was authored by someone who has published elsewhere on central pain, but in this article, he displays graphs showing post stroke CP, but omits post SCI pain. This seems odd since the prior article in Neurology is very specific about Post SCI pain. That article was effusive in including the various "proven" treatments, and indicated that various remedies had been effective for the central pain syndromes including antiepileptics, opioids, etc. Other than the one article cited recently here by Dr. Young the only prospective double blind sutdy on any neuropathic pain cure I have seen has been on postherpectic neuralgia and elavil, not on central pain.
Yet, these are the very therapies that have been questioned repeatedly over the years. Authors who advocated for opioids have now changed their view and are saying opioids are not the answer. It would be very difficult to find articles which quantify ANYTHING when talking about pain benefit, often omitting any discussion or objective criteria of quantification of benefit which even remotely resembles a double blind or prospective data array, or anything resembling what is normally required in any other field of medicine.
Double blindedness and prospective study design don't seem to have arrived in central pain publications. Anyone who looks at the history of medicine knows how perilous and delusional studies can get if they lack proper design.
I welcome ANY publicity given to the pain states, but cannot understand the omission of CP. The article by Nicholson had many impressive graphs on benefits to life style from various approaches, but I become uneasy about such items as "benefit" or "improvement" since they are nowhere quantified.
Do we say if something shows 5% improvement in a relatively small cohort of patients, that we have shown the drug is actually effective. Even if there is one hundred percent "benefit", the same might be said for almost any sedative. This is the sort of "benefit" that fuels much of the herbal medicine, "natural" remedy industry--lacking specific quantification that allows the public to know if the benefit is significant.
If I have cancer, we can talk about survival in five years, but showing that someone was more active in life doesn't necessarily mean the pain was better. I admit we do a crummy job of verbalizing central pain to doctors, but sometimes I think they do an equally crummy job of evaluating therapies. "Ideas must be distinct before reason can act on them"--Thos. Jefferson.
Talk of pain benefit was behind the decades of mistaken belief that removal of the superioir cervical ganglion stopped sympathetically maintained pain. The same sort of language is in all the now disproven literature on the benefit of opioids for central pain. There are elaborate studies on the benefit of Neurontin but very little to show it stops severe burning in CP. Can we expect any difference in Pregabalin (Lyrica) when both drugs, Neurontin and Pregabalin are said to block the same chemical step. I wonder if the severity of pain allows a lot of adventuring without hard data, if severe pain makes people crazy and almost any change in that is considered a benefit worth being called a pain treatment. I hope I am wrong. None of it has done anything for me and so I have to ask these questions. Does the emperor have any clothes on???
Now the entire condition of post SCI pain is not displayed in a review article granting continuing medical education credit to doctors and nurses on a national site. John Bonica estimated there were at least one hundred thousand with post SCI pain and related conditions. The omission might make doctors LESS aware of SCI central pain than more aware of how to receive pain complaints. It always helps if people have at least HEARD of something.
One has to wonder if the doctors are actually seeing and treeting much Post SCI pain if they forget to mention it; or should we pay attention only to the docs in rehab units, since they seem to be quite familiar with CP.
This whole business is unnerving. Pain experts who fail to include the most severe variety of neuropathic pain???
[This message was edited by dejerine on 04-14-05 at 02:46 PM.]
See
http://www.neurology.org/cgi/content/abstract/62/5_suppl_2/S30
It was authored by someone who has published elsewhere on central pain, but in this article, he displays graphs showing post stroke CP, but omits post SCI pain. This seems odd since the prior article in Neurology is very specific about Post SCI pain. That article was effusive in including the various "proven" treatments, and indicated that various remedies had been effective for the central pain syndromes including antiepileptics, opioids, etc. Other than the one article cited recently here by Dr. Young the only prospective double blind sutdy on any neuropathic pain cure I have seen has been on postherpectic neuralgia and elavil, not on central pain.
Yet, these are the very therapies that have been questioned repeatedly over the years. Authors who advocated for opioids have now changed their view and are saying opioids are not the answer. It would be very difficult to find articles which quantify ANYTHING when talking about pain benefit, often omitting any discussion or objective criteria of quantification of benefit which even remotely resembles a double blind or prospective data array, or anything resembling what is normally required in any other field of medicine.
Double blindedness and prospective study design don't seem to have arrived in central pain publications. Anyone who looks at the history of medicine knows how perilous and delusional studies can get if they lack proper design.
I welcome ANY publicity given to the pain states, but cannot understand the omission of CP. The article by Nicholson had many impressive graphs on benefits to life style from various approaches, but I become uneasy about such items as "benefit" or "improvement" since they are nowhere quantified.
Do we say if something shows 5% improvement in a relatively small cohort of patients, that we have shown the drug is actually effective. Even if there is one hundred percent "benefit", the same might be said for almost any sedative. This is the sort of "benefit" that fuels much of the herbal medicine, "natural" remedy industry--lacking specific quantification that allows the public to know if the benefit is significant.
If I have cancer, we can talk about survival in five years, but showing that someone was more active in life doesn't necessarily mean the pain was better. I admit we do a crummy job of verbalizing central pain to doctors, but sometimes I think they do an equally crummy job of evaluating therapies. "Ideas must be distinct before reason can act on them"--Thos. Jefferson.
Talk of pain benefit was behind the decades of mistaken belief that removal of the superioir cervical ganglion stopped sympathetically maintained pain. The same sort of language is in all the now disproven literature on the benefit of opioids for central pain. There are elaborate studies on the benefit of Neurontin but very little to show it stops severe burning in CP. Can we expect any difference in Pregabalin (Lyrica) when both drugs, Neurontin and Pregabalin are said to block the same chemical step. I wonder if the severity of pain allows a lot of adventuring without hard data, if severe pain makes people crazy and almost any change in that is considered a benefit worth being called a pain treatment. I hope I am wrong. None of it has done anything for me and so I have to ask these questions. Does the emperor have any clothes on???
Now the entire condition of post SCI pain is not displayed in a review article granting continuing medical education credit to doctors and nurses on a national site. John Bonica estimated there were at least one hundred thousand with post SCI pain and related conditions. The omission might make doctors LESS aware of SCI central pain than more aware of how to receive pain complaints. It always helps if people have at least HEARD of something.
One has to wonder if the doctors are actually seeing and treeting much Post SCI pain if they forget to mention it; or should we pay attention only to the docs in rehab units, since they seem to be quite familiar with CP.
This whole business is unnerving. Pain experts who fail to include the most severe variety of neuropathic pain???
[This message was edited by dejerine on 04-14-05 at 02:46 PM.]